Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...
Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly ...
Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...
As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
The Tennessee high school swimming season concluded with the TISCA championships this weekend. Here are five takeaways from ...
Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of ...
This show is especially important to Reese and her pals because it marks the debut of her first single, which features vocals ...
Lilly upgraded its 2025 guidance to between $58 billion to $61 billion, slightly higher than Wall Street expectations by $1 ...
TALLAHASSEE, Fla. (WCJB) - Hit-and-run crashes across Florida have gone up 40 percent in the last decade according to new ...
Schedule, scores, stats Sectional 8 wrap: Maya Makalusky shares win with sister; Westfield seniors say goodbye There were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback